• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症诱导的凝血病评分与脓毒症患者新发心房颤动风险增加相关:一项双中心回顾性研究

Sepsis-Induced Coagulopathy Score is Associated with an Increased Risk of New-Onset Atrial Fibrillation in Septic Patients: A Two-Centered Retrospective Study.

作者信息

Li Juan, Wang Shu, Ma Chaoping, Ning Ning, Huang Yingying, Jiao Min, Zhang Jiyuan, Sun Wenwu, Li Jiaoyan, Zhao Bing, Mao Enqiang, Che Zaiqian, Gao Chengjin

机构信息

Department of Emergency, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.

Department of Intensive Care Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing, 400016, People's Republic of China.

出版信息

J Inflamm Res. 2024 Aug 30;17:5889-5899. doi: 10.2147/JIR.S467424. eCollection 2024.

DOI:10.2147/JIR.S467424
PMID:39228679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370781/
Abstract

PURPOSE

New-onset atrial fibrillation (NOAF) and sepsis-induced coagulopathy (SIC) are severe complications in septic patients. However, the relationship between NOAF and SIC score has not been clearly defined. This study aims to investigate the association between SIC score and NOAF, as well as their effect on mortality in sepsis.

PATIENTS AND METHODS

This study was a two-center retrospective analysis. Medical data were collected from patients diagnosed with sepsis. The patients were divided into NOAF and non-NOAF groups, and the SIC score was calculated for each group. Univariable and multivariable logistic regression analyses were performed to explore the relationship between the SIC score and NOAF, as well as their effects on mortality. The Kaplan-Meier curve was used to assess the survival rate.

RESULTS

A total of 2,280 septic patients were included, with 132 (5.7%) suffering from NOAF. Multivariable logistic regression analyses indicated that age, gender, the Acute Physiology and Chronic Health Evaluation II score (APACHE II), heart rate, renal failure, stroke, chronic obstructive pulmonary disease (COPD), and the SIC score were independent risk factors for NOAF in sepsis. Moreover, NOAF was associated with an increased risk of in-hospital mortality, 28-day mortality, and 90-day mortality. These results were consistent across subgroup analyses.

CONCLUSION

The SIC score was an independent risk factor for NOAF in septic patients, and NOAF was an independent risk factor for predicting mortality.

摘要

目的

新发房颤(NOAF)和脓毒症诱导的凝血病(SIC)是脓毒症患者的严重并发症。然而,NOAF与SIC评分之间的关系尚未明确界定。本研究旨在探讨SIC评分与NOAF之间的关联,以及它们对脓毒症患者死亡率的影响。

患者与方法

本研究为两中心回顾性分析。收集诊断为脓毒症患者的医疗数据。将患者分为NOAF组和非NOAF组,并计算每组的SIC评分。进行单变量和多变量逻辑回归分析,以探讨SIC评分与NOAF之间的关系及其对死亡率的影响。采用Kaplan-Meier曲线评估生存率。

结果

共纳入2280例脓毒症患者,其中132例(5.7%)患有NOAF。多变量逻辑回归分析表明,年龄、性别、急性生理与慢性健康状况评分系统II(APACHE II)、心率、肾衰竭、中风、慢性阻塞性肺疾病(COPD)和SIC评分是脓毒症患者发生NOAF的独立危险因素。此外,NOAF与住院死亡率、28天死亡率和90天死亡率增加的风险相关。这些结果在亚组分析中是一致的。

结论

SIC评分是脓毒症患者发生NOAF的独立危险因素,而NOAF是预测死亡率的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/be80b8d06fa4/JIR-17-5889-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/0d9413bda565/JIR-17-5889-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/d99f4c049f62/JIR-17-5889-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/be80b8d06fa4/JIR-17-5889-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/0d9413bda565/JIR-17-5889-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/d99f4c049f62/JIR-17-5889-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f49/11370781/be80b8d06fa4/JIR-17-5889-g0003.jpg

相似文献

1
Sepsis-Induced Coagulopathy Score is Associated with an Increased Risk of New-Onset Atrial Fibrillation in Septic Patients: A Two-Centered Retrospective Study.脓毒症诱导的凝血病评分与脓毒症患者新发心房颤动风险增加相关:一项双中心回顾性研究
J Inflamm Res. 2024 Aug 30;17:5889-5899. doi: 10.2147/JIR.S467424. eCollection 2024.
2
Myeloperoxidase and its derivative hypochlorous acid combined clinical indicators predict new-onset atrial fibrillation in sepsis: a case-control study.髓过氧化物酶及其衍生物次氯酸结合临床指标预测脓毒症新发心房颤动:病例对照研究。
BMC Cardiovasc Disord. 2024 Jul 19;24(1):377. doi: 10.1186/s12872-024-04034-3.
3
[Predictive value of sepsis-induced coagulopathy score on 30-day mortality in septic patients].[脓毒症诱导的凝血病评分对脓毒症患者30天死亡率的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Dec;34(12):1263-1267. doi: 10.3760/cma.j.cn121430-20220830-00805.
4
Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.脓毒症患者新发房颤的患病率及相关结局:一项系统评价和荟萃分析
J Pers Med. 2022 Mar 30;12(4):547. doi: 10.3390/jpm12040547.
5
Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction.CHA2DS2-VASc 评分联合 hs-CRP 对老年急性心肌梗死患者新发心房颤动的预测价值。
BMC Cardiovasc Disord. 2021 Apr 13;21(1):175. doi: 10.1186/s12872-021-01978-8.
6
Study protocol: A systematic review and meta-analysis regarding the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis.研究方案:关于凝血功能障碍和免疫激活对脓毒症患者新发心房颤动影响的系统评价和荟萃分析。
PLoS One. 2023 Sep 8;18(9):e0290963. doi: 10.1371/journal.pone.0290963. eCollection 2023.
7
New-onset atrial fibrillation in critically ill acute kidney injury patients on renal replacement therapy.重症急性肾损伤行肾脏替代治疗患者新发心房颤动。
Europace. 2022 Feb 2;24(2):211-217. doi: 10.1093/europace/euab163.
8
The value of syntax score to predict new-onset atrial fibrillation in patients with acute coronary syndrome.句法评分对预测急性冠脉综合征患者新发房颤的价值。
Ann Noninvasive Electrocardiol. 2019 Jul;24(4):e12622. doi: 10.1111/anec.12622. Epub 2019 Jan 7.
9
Development of a Nomogram to Predict 28-Day Mortality of Patients With Sepsis-Induced Coagulopathy: An Analysis of the MIMIC-III Database.预测脓毒症诱导的凝血病患者28天死亡率的列线图的开发:MIMIC-III数据库分析
Front Med (Lausanne). 2021 Apr 6;8:661710. doi: 10.3389/fmed.2021.661710. eCollection 2021.
10
Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.新发房颤合并急性心肌梗死对心力衰竭的长期影响。
ESC Heart Fail. 2020 Oct;7(5):2762-2772. doi: 10.1002/ehf2.12872. Epub 2020 Jun 23.

引用本文的文献

1
Sepsis-induced Atrial Fibrillation: Can We Predict and Prevent This High-Risk Complication?脓毒症诱发的心房颤动:我们能否预测并预防这种高风险并发症?
Cureus. 2025 Jun 5;17(6):e85387. doi: 10.7759/cureus.85387. eCollection 2025 Jun.

本文引用的文献

1
Sepsis-induced coagulopathy is associated with new episodes of atrial fibrillation in patients admitted to critical care in sinus rhythm.脓毒症诱发的凝血病与窦性心律的危重症患者新发房颤事件相关。
Front Med (Lausanne). 2023 Sep 15;10:1230854. doi: 10.3389/fmed.2023.1230854. eCollection 2023.
2
Elevated thrombin generation levels in the left atrial appendage in patients with atrial fibrillation.心房颤动患者左心耳中凝血酶生成水平升高。
Res Pract Thromb Haemost. 2023 Mar 15;7(2):100127. doi: 10.1016/j.rpth.2023.100127. eCollection 2023 Feb.
3
Neutrophils restrain sepsis associated coagulopathy via extracellular vesicles carrying superoxide dismutase 2 in a murine model of lipopolysaccharide induced sepsis.
中性粒细胞通过携带超氧化物歧化酶 2 的细胞外囊泡来抑制脂多糖诱导的脓毒症相关凝血障碍:一项在脓毒症小鼠模型中的研究。
Nat Commun. 2022 Aug 6;13(1):4583. doi: 10.1038/s41467-022-32325-w.
4
Beneficial Effect of Edoxaban on Preventing Atrial Fibrillation and Coagulation by Reducing Inflammation HBG1/HBD Biomarkers.依度沙班通过降低炎症HBG1/HBD生物标志物预防心房颤动和凝血的有益作用。
Front Pharmacol. 2022 Jun 3;13:904317. doi: 10.3389/fphar.2022.904317. eCollection 2022.
5
Endothelial function and atrial fibrillation: A missing piece of the puzzle?内皮功能与心房颤动:拼图缺失的一块?
J Cardiovasc Electrophysiol. 2022 Jan;33(1):109-116. doi: 10.1111/jce.15277. Epub 2021 Nov 9.
6
Early Coagulation Disorder Is Associated With an Increased Risk of Atrial Fibrillation in Septic Patients.早期凝血功能障碍与脓毒症患者发生心房颤动的风险增加相关。
Front Cardiovasc Med. 2021 Sep 30;8:724942. doi: 10.3389/fcvm.2021.724942. eCollection 2021.
7
The pathophysiology of sepsis-2021 update: Part 1, immunology and coagulopathy leading to endothelial injury.脓毒症的病理生理学-2021 更新:第 1 部分,导致内皮损伤的免疫和凝血障碍。
Am J Health Syst Pharm. 2022 Feb 18;79(5):329-337. doi: 10.1093/ajhp/zxab380.
8
Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment.凝血功能障碍和脓毒症:病理生理学、临床表现和治疗。
Blood Rev. 2021 Nov;50:100864. doi: 10.1016/j.blre.2021.100864. Epub 2021 Jun 25.
9
Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model.血栓调节蛋白对脂多糖诱导的脓毒性休克模型肺和肝组织中中性粒细胞胞外诱捕网形成及致死率的影响。
Int J Mol Sci. 2021 May 6;22(9):4933. doi: 10.3390/ijms22094933.
10
Disseminated intravascular coagulation: epidemiology, biomarkers, and management.弥散性血管内凝血:流行病学、生物标志物和治疗。
Br J Haematol. 2021 Mar;192(5):803-818. doi: 10.1111/bjh.17172. Epub 2021 Feb 8.